logo-large
  • Browse Categories

Publications by authors named "James Crawforth"

Claim this Profile
T
The discovery and optimization of benzimidazoles as selective Na1.8 blockers for the treatment of pain.
Alan D Brown, Sharan K Bagal, Paul Blackwell, David C Blakemore, Bruce Brown, James Crawforth

Bioorg Med Chem· January 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II.
Jason M Elliott, Robert W Carling, Gary G Chicchi, James Crawforth, Peter H Hutson

Bioorg Med Chem Lett· November 2006


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety disorders.
Simon C Goodacre, Leslie J Street, David J Hallett, James M Crawforth, Sarah Kelly

J Med Chem· January 2006


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tricyclic pyridones as functionally selective human GABAA alpha 2/3 receptor-ion channel ligands.
James Crawforth, John R Atack, Susan M Cook, Karl R Gibson, Alan Nadin

Bioorg Med Chem Lett· April 2004


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: